Compare BIRK & EMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BIRK | EMN |
|---|---|---|
| Founded | 1774 | 1920 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | | Major Chemicals |
| Sector | | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.5B | 8.1B |
| IPO Year | 2023 | 1996 |
| Metric | BIRK | EMN |
|---|---|---|
| Price | $44.41 | $70.69 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 14 | 13 |
| Target Price | $61.43 | ★ $79.31 |
| AVG Volume (30 Days) | ★ 2.4M | 989.5K |
| Earning Date | 05-13-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 4.77% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.93 |
| Revenue | N/A | ★ $8,752,000,000.00 |
| Revenue This Year | $13.71 | $3.06 |
| Revenue Next Year | $14.30 | $3.47 |
| P/E Ratio | ★ $17.48 | $75.95 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $31.33 | $56.11 |
| 52 Week High | $53.53 | $83.47 |
| Indicator | BIRK | EMN |
|---|---|---|
| Relative Strength Index (RSI) | 53.27 | 40.72 |
| Support Level | $40.81 | $66.33 |
| Resistance Level | $45.80 | $71.34 |
| Average True Range (ATR) | 2.27 | 1.97 |
| MACD | -0.43 | -0.40 |
| Stochastic Oscillator | 29.83 | 9.77 |
Birkenstock is a German footwear brand known for comfort-focused, timeless designs, with 76% of 2022 sales coming from its top five iconic models. Products are made in Europe using sustainable, mostly locally sourced materials. The brand combines orthopedic function with everyday style, appealing to a broad audience. The Americas account for 52% of sales, EMEA 37%, with the remainder coming from Asia-Pacific, which has also the higher future growth expectations.
Established in 1920 to produce chemicals for Eastman Kodak, Eastman Chemical has grown into a global specialty chemical company with manufacturing sites around the world. The company generates the majority of its sales outside of the United States, with a strong presence in Asian markets. During the past several years, Eastman has sold noncore businesses, choosing to focus on higher-margin specialty product offerings.